Pandey A. HBV Pre-S Mutants and Hepatocellular Carcinoma: New Molecular Pathways, Clinical Implications, and Therapeutic Horizons (2020–2025). JEPMR. 2025;1(2):87-126. Accessed August 29, 2025. https://jepmr.nknpub.com/1/article/view/9